Corneal confocal microscopy is helpful in VKC

Article

Corneal confocal microscopy is useful for studying in vivo pathologic corneal changes in vernal keratoconjunctivitis (VKC).

Corneal confocal microscopy is useful for studying in vivo pathologic corneal changes in vernal keratoconjunctivitis (VKC), claims a study in the journal Ophthalmology.

Dr Andrea Leonardi et al., Department of Neuroscience, Ophthalmology Unit, University of Padova, Padova, Italy, completed a prospective, comparative case study on 32 patients with VKC and 40 normal participants.

All patients underwent a full ophthalmic examination and central cornea images were gathered using a x40 non-contact lens and a Z-ring device. The main outcome measures were the superficial and basal epithelium, subbasal nerve plexus, anterior stroma, stromal nerves and endothelium of the central cornea.

It was discovered that the VKC patients had increased diameter, reflectivity and presence of nuclear activation of superficial epithelial cells. They also had a reduced basal membrane density, an increased presence of activated keratocytes and inflammatory cells in the anterior stroma.

The VKC patients also presented with lower density and number of fibres, lower number of beadings and a higher grade of tortuosity of fibres in the subbasal nerve plexus. In the stromal corneal nerves there was an increased thickness, deflections and tortuosity changes.

The study authors concluded that the changes in the epithelium and subbasal and stromal corneal nerves could be linked to tear dysfunction and non-specific hyperactivity.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.